CommonHealth Recovery


Generally, the purpose of drug testing during treatment of opioid use disorder is to monitor the effectiveness of a patient’s treatment plan. Drug testing should be viewed and used as a therapeutic tool. CommonHealth will administer drug/alcohol tests to maintain a safe, drug and alcohol-free environment and assist clients in being accountable for their treatment. 

Alcohol and drug testing is allowable at all levels of care. The frequency of alcohol and drug testing should be based on the beneficiary’s progress in treatment, and the frequency of testing should be higher during the initial phases of treatment when continued alcohol and/or drug use has been identified as happening higher in frequency. 

Drug testing is initiated in the following situations: 

  • When a client first begins CommonHealth services.
  • Before a client is discharged from CommonHealth Services.
  • Randomly throughout the duration of the services that CommonHealth Provides.
  • When any client is suspected of being under the influence of any substance, at the discretion of staff (can be on routine or random basis).
  • At the request of any agencies approved via consent (drug court, probation/parole, etc.).

Each drug test performed shall at a minimum screen the following drug classes: 

  • Buprenorphine;
  • Methadone;
  • Oxycodone;
  • Other Opioids;
  • THC;
  • Benzodiazepines;
  • Amphetamines; and
  • Cocaine.

Other drug classes can be tested for at the discretion of the treatment team and confirmation on each test can be ordered if necessary in accordance with the individualized treatment plan. 

CommonHealth will administer drug tests to maintain a safe, drug- and alcohol-free environment, and assist clients in being accountable for their actions.  Staff will respond to clients with positive drug screens in a fair and consistent manner.

Clients showing a positive drug screen will be handled in one of the following manners: 

  1. If a beneficiary acknowledges use of drugs or alcohol, they may be given the opportunity to remain in the program and address their use in therapy.
  2. If a beneficiary demonstrates characteristics or symptoms of use, beneficiary may be removed from the current session per staff discretion and may be terminated from the program per discretion of the administrator.
  3. If a client denies use despite a positive drug test, and they demonstrate no obvious sign of use, a second drug test is performed. If the second test is negative for drugs, the client is returned to previous status.  If the second test is positive for drugs, client may be removed from the current session, test may be sent to the lab and/or client may be terminated from the program per discretion of the administrator.
  4. Staff may make a decision to send a client’s positive drug screen out for confirmation.
  5. Staff will inform client of the result of laboratory tests.

What happens if a patient relapses during treatment?

Relapse is part of the disease of addiction. Patients relapse for all kinds of reasons; a death in the family, loss of employment, a move, a fight with a significant other or family member, or any other type of stressor. What is most important about a relapse is that the patient gets back into treatment as soon as possible. The risk of overdose and death during a relapse is highest. We understand the dynamics of addiction therefore we assist patients through tough times by getting them back on track through regularly scheduled therapy and counseling sessions or elevate thier treatment to a higher level of care.